The role of osteoclast-associated receptor in osteoimmunology

Journal of Immunology

Volumn 186, Issue 1, 2011, Pages 13-18

  Nemeth, Katharina ^a   Schoppet, Michael ^a   Al Fakhri, Nadia ^a   Helas, Susann ^b   Jessberger, Rolf ^b,c   Hofbauer, Lorenz C ^b,c   Goettsch, Claudia ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; COLONY STIMULATING FACTOR 1; FC RECEPTOR; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 8; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; OSTEOCLAST ASSOCIATED RECEPTOR; OSTEOCLAST ASSOCIATED RECEPTOR IMMUNOGLOBULIN FUSION PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN INHIBITOR; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR PU 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR;

ADAPTIVE IMMUNITY; ALBERS SCHOENBERG DISEASE; ANTIGEN PRESENTATION; BONE; BONE DESTRUCTION; BYSTANDER EFFECT; CARTILAGE INJURY; CELL MATURATION; CELL MOTILITY; CELL SURVIVAL; DENDRITIC CELL; ENDOTHELIUM CELL; FRAGILITY FRACTURE; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INNATE IMMUNITY; MONOCYTE; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOIMMUNOLOGY; OSTEOLYSIS; POSITIVE FEEDBACK; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SHORT SURVEY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ACTIVITY RELATION;

ANIMALS; BONE AND BONES; BONE RESORPTION; CELL COMMUNICATION; HUMANS; OSTEOCLASTS; RECEPTOR CROSS-TALK; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79251556230     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002483     Document Type: Short Survey

References (50)

1. Calvi, L. M., G. B. Adams, K. W. Weibrecht, J. M. Weber, D. P. Olson, M. C. Knight, R. P. Martin, E. Schipani, P. Divieti, F. R. Bringhurst, et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841-846.
2. Arai, F., and T. Suda. 2007. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann. N. Y. Acad. Sci. 1106: 41-53.
3. Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, et al. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428: 758-763. (Pubitemid 38508286)
4. Hofbauer, L. C., and M. Schoppet. 2004. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292: 490-495.
5. Weiss, J. M., A. C. Renkl, C. S. Maier, M. Kimmig, L. Liaw, T. Ahrens, S. Kon, M. Maeda, H. Hotta, T. Uede, and J. C. Simon. 2001. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J. Exp. Med. 194: 1219-1229.
6. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3: 889-901.
7. Walsh, M. C., N. Kim, Y. Kadono, J. Rho, S. Y. Lee, J. Lorenzo, and Y. Choi. 2006. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24: 33-63.
8. Lorenzo, J., M. Horowitz, and Y. Choi. 2008. Osteoimmunology: interactions of the bone and immune system. Endocr. Rev. 29: 403-440.
9. Kim, N., M. Takami, J. Rho, R. Josien, and Y. Choi. 2002. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 195: 201-209.
10. Merck, E., C. Gaillard, D. M. Gorman, F. Montero-Julian, I. Durand, S. M. Zurawski, C. Menetrier-Caux, G. Carra, S. Lebecque, G. Trinchieri, and E. E. Bates. 2004. OSCAR is an FcRgamma-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells. Blood 104: 1386-1395.
11. Merck, E., B. de Saint-Vis, M. Scuiller, C. Gaillard, C. Caux, G. Trinchieri, and E. E. Bates. 2005. Fc receptor gamma-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responses. Blood 105: 3623-3632.
12. Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
13. Lee, T. H., K. L. Fevold, Y. Muguruma, J. L. Lottsfeldt, and M. Y. Lee. 1994. Relative roles of osteoclast colony-stimulating factor and macrophage colony-stimulating factor in the course of osteoclast development. Exp. Hematol. 22: 66-73.
14. Woo, K. M., H. M. Kim, and J. S. Ko. 2002. Macrophage colony-stimulating factor promotes the survival of osteoclast precursors by up-regulating Bcl-X(L). Exp. Mol. Med. 34: 340-346.
15. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
16. Kong, Y. Y., U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. Elliott, S. McCabe, et al. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 304-309.
17. Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
18. Anderson, K. L., K. A. Smith, K. Conners, S. R. McKercher, R. A. Maki, and B. E. Torbett. 1998. Myeloid development is selectively disrupted in PU.1 null mice. Blood 91: 3702-3710.
19. Tondravi, M. M., S. R. McKercher, K. Anderson, J. M. Erdmann, M. Quiroz, R. Maki, and S. L. Teitelbaum. 1997. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386: 81-84.
20. Mócsai, A., M. B. Humphrey, J. A. Van Ziffle, Y. Hu, A. Burghardt, S. C. Spusta, S. Majumdar, L. L. Lanier, C. A. Lowell, and M. C. Nakamura. 2004. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. USA 101: 6158-6163.
21. So, H., J. Rho, D. Jeong, R. Park, D. E. Fisher, M. C. Ostrowski, Y. Choi, and N. Kim. 2003. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J. Biol. Chem. 278: 24209-24216.
22. Ishikawa, S., N. Arase, T. Suenaga, Y. Saita, M. Noda, T. Kuriyama, H. Arase, and T. Saito. 2004. Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR). Int. Immunol. 16: 1019-1025. (Pubitemid 38960880)
23. Borrego, F., J. Kabat, D. K. Kim, L. Lieto, K. Maasho, J. Peña, R. Solana, and J. E. Coligan. 2002. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol. Immunol. 38: 637-660.
24. Fanger, N. A., D. Cosman, L. Peterson, S. C. Braddy, C. R. Maliszewski, and L. Borges. 1998. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 28: 3423-3434.
25. Herman, S., R. B. Müller, G. Krönke, J. Zwerina, K. Redlich, A. J. Hueber, H. Gelse, E. Neumann, U. Müller-Ladner, and G. Schett. 2008. Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis. Arthritis Rheum. 58: 3041-3050.
26. Kim, Y., K. Sato, M. Asagiri, I. Morita, K. Soma, and H. Takayanagi. 2005. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis. J. Biol. Chem. 280: 32905-32913.
27. Kim, K., J. H. Kim, J. Lee, H. M. Jin, S. H. Lee, D. E. Fisher, H. Kook, K. K. Kim, Y. Choi, and N. Kim. 2005. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J. Biol. Chem. 280: 35209-35216.
28. Kim, J. H., K. Kim, H. M. Jin, B. U. Youn, I. Song, H. S. Choi, and N. Kim. 2008. Upstream stimulatory factors regulate OSCAR gene expression in RANKL-mediated osteoclast differentiation. J. Mol. Biol. 383: 502-511.
29. Kim, J. H., H. M. Jin, K. Kim, I. Song, B. U. Youn, K. Matsuo, and N. Kim. 2009. The mechanism of osteoclast differentiation induced by IL-1. J. Immunol. 183: 1862-1870.
30. Kim, K., J. H. Kim, J. Lee, H. M. Jin, H. Kook, K. K. Kim, S. Y. Lee, and N. Kim. 2007. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109: 3253-3259.
31. Kim, K., J. Lee, J. H. Kim, H. M. Jin, B. Zhou, S. Y. Lee, and N. Kim. 2007. Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor. J. Immunol. 178: 5588-5594.
32. Lee, J., K. Kim, J. H. Kim, H. M. Jin, H. K. Choi, S. H. Lee, H. Kook, K. K. Kim, Y. Yokota, S. Y. Lee, et al. 2006. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood 107: 2686-2693.
33. Park, J. Y., M. A. Bae, H. G. Cheon, S. S. Kim, J. M. Hong, T. H. Kim, J. Y. Choi, S. H. Kim, J. Lim, C. H. Choi, et al. 2009. A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways. Biochem. Biophys. Res. Commun. 378: 645-649.
34. Kim, J. H., K. Kim, H. M. Jin, I. Song, B. U. Youn, J. Lee, and N. Kim. 2009. Silibinin inhibits osteoclast differentiation mediated by TNF family members. Mol. Cells 28: 201-207.
35. Kim, J. H., K. Kim, B. U. Youn, H. M. Jin, and N. Kim. 2010. MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR. Cell. Signal. 22: 1341-1349.
36. Merck, E., C. Gaillard, M. Scuiller, P. Scapini, M. A. Cassatella, G. Trinchieri, and E. E. Bates. 2006. Ligation of the FcR gamma chain-associated human osteoclast-associated receptor enhances the proinflammatory responses of human monocytes and neutrophils. J. Immunol. 176: 3149-3156.
37. Miyamoto, T., O. Ohneda, F. Arai, K. Iwamoto, S. Okada, K. Takagi, D. M. Anderson, and T. Suda. 2001. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98: 2544-2554.
38. Coquerelle, C., and M. Moser. 2010. DC subsets in positive and negative regulation of immunity. Immunol. Rev. 234: 317-334.
39. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
40. Geissmann, F., S. Gordon, D. A. Hume, A. M. Mowat, and G. J. Randolph. 2010. Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol. 10: 453-460.
41. Helft, J., F. Ginhoux, M. Bogunovic, and M. Merad. 2010. Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice. Immunol. Rev. 234: 55-75.
42. Visintin, A., A. Mazzoni, J. H. Spitzer, D. H. Wyllie, S. K. Dower, and D. M. Segal. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166: 249-255.
43. Baggiolini, M. 1993. Chemotactic and inflammatory cytokines - CXC and CC proteins. Adv. Exp. Med. Biol. 351: 1-11.
44. Mukaida, N. 2003. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L566-L577.
45. Tenca, C., A. Merlo, E. Merck, E. E. Bates, D. Saverino, R. Simone, D. Zarcone, G. Trinchieri, C. E. Grossi, and E. Ciccone. 2005. CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells. J. Immunol. 174: 6757-6763. (Pubitemid 40705638)
46. Wong, B. R., R. Josien, S. Y. Lee, B. Sauter, H. L. Li, R. M. Steinman, and Y. Choi. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186: 2075-2080.
47. Chino, T., K. E. Draves, and E. A. Clark. 2009. Regulation of dendritic cell survival and cytokine production by osteoprotegerin. J. Leukoc. Biol. 86: 933-940.
48. Choi, J., D. R. Enis, K. P. Koh, S. L. Shiao, and J. S. Pober. 2004. T lymphocyte-endothelial cell interactions. Annu. Rev. Immunol. 22: 683-709.
49. Kim, G. S., J. M. Koh, J. S. Chang, B. L. Park, L. H. Kim, E. K. Park, S. Y. Kim, and H. D. Shin. 2005. Association of the OSCAR promoter polymorphism with BMD in postmenopausal women. J. Bone Miner. Res. 20: 1342-1348.
50. Andersson, M. K., P. Lundberg, A. Ohlin, M. J. Perry, A. Lie, A. Stark, and U. H. Lerner. 2007. Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patients. Arthritis Res. Ther. 9: R18.